MedTrace Logo

Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women

NCT02968342 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-10-20

No results posted yet for this study

Summary

The objective of this study is the role of vaginal progesterone gel in the treatment of menopausal hypoactive sexual desire disorder. Half of the study participants will receive a standard dose of self applied vaginal progesterone gel and the other half will receive oral vitamin tablets.

Conditions

  • Menopause
  • Sexual Desire Disorder
  • Hypoactive Sexual Desire Disorder

Interventions

DEVICE

Vaginal progesterone 8%

vaginal self application

Sponsors & Collaborators

  • Bezmialem Vakif University

    lead OTHER

Principal Investigators

  • Serdar G Aydin, M.D · Bezmialem Üniversitesi Tıp Fakültesi Hastanesi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02968342 on ClinicalTrials.gov